Blog

My plan says my treatment is experimental: how do I answer that?

Steps for answering an experimental or investigational denial: get the exact exclusion, separate approval status from standard of care, build evidence, appeal.

If your plan has denied a treatment as experimental or investigational, you can answer it, and the answer is built from documents rather than from emotion. The plan is applying a definition in its contract. Your job, with your treating specialist, is to show either that your treatment does not meet that definition or that your circumstances justify an exception, and to do it in the order below, quickly if your condition is serious.

This playbook assumes a patient with a serious condition whose treating specialist has recommended a treatment the plan labels experimental. It is not medical advice. Whether the treatment is right for you is a matter for your doctors, and the appeal is a way to ask the plan to pay for what they recommend.

Step 1: Get the exact exclusion and the criteria

"Experimental" is a label with a definition, and the definition is in your coverage documents, usually in a glossary or in the exclusions section. Requests that change the outcome start with the actual words.

Ask the plan, in writing, for:

  • The exact language of the exclusion or definition it relied on.
  • The coverage policy or criteria the reviewer applied to your treatment, with its title and date.
  • The reviewer's explanation of how the plan's terms apply to your condition. For decisions based on experimental treatment or medical necessity, federal claims rules entitle you to an explanation of the clinical or scientific judgment, or a statement that it is available free on request.
  • The complete claim or request file, free of charge.

Common elements in plan definitions, though yours may differ, include that the treatment is not approved by the regulator for the use in question, that it lacks enough published evidence of safety and effectiveness, that it is the subject of ongoing clinical trials, or that it is not the standard of care. Read which of these your plan actually relies on. A denial may rest on only one, and a single element is easier to contest than the whole concept. The post letter of medical necessity worksheet: what to give your doctor has a worksheet that complements this step.

Step 2: Separate regulatory status from standard of care

Two ideas get tangled in these denials, and pulling them apart often finds the strongest argument.

  • Regulatory status is whether the U.S. Food and Drug Administration has approved, cleared or authorized the drug, device or test, and for which uses. Approval is for specific uses listed on the label.
  • Standard of care is what the treating specialty recognizes as appropriate for patients like you, reflected in clinical practice guidelines and the published literature.

The table shows how the two can combine, with generic examples.

Situation What it means How a plan may label it
Approved drug, used as the label says Regulatory status and standard of care agree Rarely disputed; a necessity or criteria question, not experimental
Approved drug used for a condition not on its label (off-label use) The regulator has not approved that use, but guidelines or literature may support it Often labeled experimental; may be covered if recognized references support it
Device or procedure that is cleared or approved for some uses Status depends on the exact use and patient Depends on the plan's definition
A drug still in clinical trials Not approved for anyone yet Usually excluded, apart from certain trial costs (Step 3)
A new use of an established procedure Possibly no regulatory approval step applies Labeled by evidence, not approval status

The important point is that "not approved for this use" does not mean "not standard of care." Off-label use is common and often well supported, especially in cancer care and rare diseases, and many plans cover it when a recognized reference supports the use. Which references count, such as certain drug compendia or peer-reviewed journals, varies by plan, and some states have laws about coverage of off-label drug use in particular conditions. Check your plan documents and ask your state insurance department what your state requires.

Step 3: Check the routes that sit beside the appeal

A few options run in parallel and can be worth raising with your doctor.

  • Clinical trial coverage. For a patient in an approved clinical trial for cancer or another life-threatening condition, the ACA requires non-grandfathered plans to cover the routine patient costs of care associated with the trial, such as office visits and standard tests. The investigational item itself is generally not part of that. Ask the trial team how routine costs are billed.
  • A second opinion from a specialist at a center that treats your condition often. A second doctor's written support is evidence for the appeal, and the plan may cover a second opinion.
  • Manufacturer and expanded-access programs. Some manufacturers offer a drug on a case-by-case basis outside trials, and your doctor can say whether any option exists. These are decided by the manufacturer and the regulator, not by your plan, and no one can promise access.
  • A network exception or a referral to a facility that offers the treatment, if the denial is partly about where it will be done.

Step 4: Build the evidence

Your appeal is stronger when it answers the plan's own reasons with sources a reviewer can check. Gather, with your doctor's help:

  • Clinical practice guidelines from professional societies in the relevant specialty that mention the treatment for your condition and stage, with the recommendation and its strength.
  • Peer-reviewed studies that report outcomes for patients like you, preferably the most rigorous available, such as randomized trials or large well-designed cohorts.
  • Regulatory documents, such as the drug label or approval summary, that show what is and is not approved.
  • The plan's own policies, which sometimes cover the same treatment for a different condition or cover a similar treatment, a point that bears on consistency.
  • Records showing what has been tried and why alternatives failed or are unsuitable.

A worked evidence-table layout

An evidence table lets a reviewer see your case at a glance. The version below is a template with placeholders. Fill each bracket from a real source your doctor can supply and put the table at the front of the appeal.

The plan's stated reason Source type Citation What it says in one line Where to find it Why it fits this patient
"Not standard of care" Clinical practice guideline [Society name, guideline title, year] [Recommends the treatment for this condition and stage, with strength of recommendation] [Section or table number] [Patient's diagnosis, stage and prior treatments match]
"Insufficient evidence of effectiveness" Peer-reviewed study [Authors, journal, year] [Result in the study population, in one sentence] [Abstract, results table] [How the study population resembles the patient]
"Not approved for this use" Regulatory label or approval summary [Document title and date] [What the label states; what it leaves open] [Section] [Off-label use is supported by the guideline above]
"Alternatives available" Treatment history [Medical records, dates] [Alternatives tried, results or reasons unsuitable] [Record page] [Why this patient needs this treatment]

Keep every cell factual and checkable, and do not paraphrase a study's finding more strongly than the study does. If a source is mixed, cite it as it is and have your doctor explain why it still supports the request. A reviewer who finds an overstated citation will discount the rest.

Step 5: Get a letter from the treating specialist

The strongest support is a letter from the specialist who treats your condition. It should state the diagnosis and stage, the treatments tried and their results, why the requested treatment is recommended, why standard options are inadequate or unsuitable, the guidelines and studies relied on, the expected benefit and risk, and what is likely to happen if the treatment is denied. It should answer the plan's stated reason, not only the doctor's view in general. The builder at claim denial appeal letter builder helps with your own cover letter, and how to write a health insurance appeal letter that gets read covers its structure.

Ask the specialist's office whether the doctor can also request a peer-to-peer review, a call with the plan's physician reviewer. A reviewer in the same specialty is more likely to engage with the evidence.

Step 6: File the internal appeal, and ask for speed if the situation is urgent

File the internal appeal within the deadline on the notice, which for most plans is at least 180 days from the denial. Include the evidence table, the specialist's letter, the records and your request for the criteria and the claim file. State plainly what you want: reversal of the denial and coverage of the named treatment.

If delay could seriously jeopardize your health or your ability to regain function, ask for an expedited appeal and have your doctor state that in writing. Expedited internal appeals are decided in days, and an expedited external review can sometimes be requested at the same time. The post Expedited appeal: when does my case count as urgent and how do I prove it? explains what counts as urgent and what proof helps. Keep copies of everything and the dates sent.

Step 7: Use external review

If the plan upholds its denial, you can generally ask for an independent review. A reviewer outside the plan, an independent review organization, looks at the case and the medical evidence, and denials based on experimental or investigational status are among the kinds that federal and state external review processes cover. The plan must follow the decision if the reviewer rules for you. The notice states how long you have to ask, which under the federal process for many plans is about four months from the final internal denial, and the guide external review explained: when an independent reviewer decides covers how it works. You can add new evidence at this stage, so keep collecting it.

For self-funded employer plans and some other situations, the routes differ, and the notice or the plan's documents say which process applies. If you cannot tell, a state insurance department, a patient advocate or an attorney can help.

Where the plan may have a point

Plans use the experimental label partly to avoid paying for treatments that are unproven or that carry real risk, and some of the treatments labeled experimental later turn out not to help. Supporters of strict criteria say that payers who covered every promising idea would pay for harm and would raise premiums for everyone. Patients and many doctors reply that a serious illness leaves little time for evidence to mature and that guidelines and approvals trail clinical practice. Both concerns are real. If the evidence for your treatment is thin, a frank conversation with your doctor about benefits, risks and alternatives belongs alongside the appeal, and so does a conversation about cost if the plan does not pay.

Key takeaways

  • Start with the plan's exact definition and criteria, and ask for them in writing, because the experimental label rests on specific words you can test.
  • Keep regulatory approval status separate from the standard of care: an off-label use can be well supported by guidelines and literature even when it is not on the label.
  • Build an evidence table that answers each of the plan's stated reasons with a source the reviewer can check, and add a treating-specialist letter that addresses the criteria.
  • Ask for an expedited appeal when delay could harm your health, and use independent external review if the plan upholds the denial.
  • Look into clinical-trial routine-cost coverage, a second opinion and manufacturer programs alongside the appeal, understanding that none is guaranteed.

Terms used in this guide

Related tools

Related guides

Latest on this topic